decentralized clinical trials

PharmaVoice Features Cari Kniola on Market Growth Factors and Barriers in Decentralized Clinical Trials

OCTOBER 5, 2021

Decentralized Clinical Trials may be one of the hottest buzzwords in clinical research right now, but Decentralized Clinical Trials are not new. In fact, technologies that support aspects of remote trials – such as wearables, eCOA, eConsent and Electronic health Records -have been around for awhile.

According to PharmaVoice’s recent Pulse Report on Decentralized Clinical Trials, “what is transformational is the combination of multiple technologies to seamlessly knit together a better patient journey. ”

With the market set to explode to more than $1.63 billion by 2027, read what Aperio’s Director of Corporate Strategy Cari Kniola and other industry thought leaders had to say about market growth factors and barriers to overcome in Decentralized Clinical Trials in PharmaVoice’s October issue of the Pulse Report. Read here.

About Aperio Clinical Outcomes

In a data driven industry, Aperio remains dedicated to transparency with clients and focused on the most important part of the process: people. Aperio provides full, customizable clinical research services across multiple therapeutic areas, as well as consulting services in Quality Assurance, Strategic Resourcing and Clinical Trial Technology. For more information: www.aperioclinical.com